Feedback / Questions
NKTR-0165 - Nektar Therap, Biolojic Design
https://www.prnewswire.com/news-releases/nektar-therapeutics-presents-first-preclinical-data-on-nktr-0165-a-tnfr2-agonist-antibody-being-developed-for-the-treatment-of-inflammatory-diseases-at-eular-2024-302170797.html
Jun 12, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next